Toward a more accurate quantitation of the activity of recombinant retroviruses: Alternatives to titer and multiplicity of infection

Journal of Virology

Volumn 74, Issue 3, 2000, Pages 1258-1266

  Andreadis, Stylianos ^a,b   Lavery, Thomas ^a   Davis, Howard E ^a   Le Doux, Joseph M ^a   Yarmush, Martin L ^a   Morgan, Jeffrey R ^a  

^a SHRINERS HOSPITALS FOR CHILDREN   (United States)

^b the State University of New York   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADSORPTION; ARTICLE; GENE THERAPY; HUMAN; HUMAN CELL; MATHEMATICAL MODEL; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RETROVIRUS; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS PARTICLE; VIRUS RECOMBINANT;

3T3 CELLS; ADSORPTION; ANIMALS; CELL COUNT; CELL LINE; CELL MEMBRANE; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; MICE; MODELS, BIOLOGICAL; RETROVIRIDAE; TRANSFECTION;

EID: 0033985650     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.3.1258-1266.2000     Document Type: Article

References (24)

1. Andreadis, S., D. A. Brott, A. O. Fuller, and B. O. Palsson. 1997. Moloney murine leukemia virus-derived retroviral vectors decay incracellularly with a half-life in the range of 5.5 to 7.5 hours. J. Virol. 71:7541-7548.
2. Andreadis, S., A. O. Fuller, and B. O. Palsson. 1998. Cell cycle dependence of retroviral transduclion: an issue of overlapping time scales. Biotechnol. Bioeng. 58:272-281.
3. Andreadis, S., and B. O. Palsson. 1996. Kinetics of retrovirus mediated gene transfer: the importance of the intracellular halt-life of retroviruses. J. Theor. Biol. 182:1-20.
4. Rahnson, A. B., J. T. Dunigan, B. E. Baysal, T. Mohney, R. W. Atchison, M. T. Nimgaonkar, E. D. Ball, and J. A. Barranger. 1995. Centrifugal enhancement of retroviral mediated gene transfer. J. Virol. Methods 54:131-143.
5. Chuck, A. S., M. F. Clarke, and B. O. Palsson. 1996. Retroviral infection is limited by Brownian motion. Hum. Gene Ther. 7:1527-1534.
6. Chuck, A. S., and B. O. Palsson. 1996. Consistent and high rates of gene transfer can be obtained using flow-through transduction over a wide range of retroviral titers. Hum. Gene Ther. 7:743-750.
7. Chuck, A. S., and B. O. Palsson. 1996. Membrane adsorption characteristics determine the kinetics of flow-through transductions. Biotechnol. Bioeng. 51:260-270.
8. Crystal, R. G. 1995. Transfer of genes to humans: early lessons and obstacles to success. Science 270:404-410.
9. Forestell, S. P., E. Bohnlein, and R. J. Rigg. 1995. Retroviral end-point titer is not predictive of gene transfer efficiency: implications for vector production. Gene Ther. 2:723-730.
10. Kahn, M. L., S. W. Lee, and D. A. Dichek. 1992. Optimization of retroviral vector-mediated gene transfer into endothelial cells in vitro. Circ. Res. 71: 1508-1517.
11. Kotani, H., P. B. I. Newton, S. Zhang, V. L. Chiang, E. Otto, L. Weaver, R M. Blaese, W. F. Anderson, and G. J. McGarrity. 1994. Improved methods of retroviral vector transduction and production for gene therapy. Hum. Gene Ther. 5:19-28.
12. LeDoux, J. M., H. E. Davis, M. L. Yarmush, and J. R. Morgan. 1999. Kinetics of retrovirus production and decay. Biotechnol. Bioeng. 63:654-662.
13. LeDoux, J. M., J. R. Morgan, and M. L. Yarmush. 1996. Proteoglycans secreted by packaging cell lines inhibit retrovirus infection. J. Virol. 70:6468-6473.
14. Miller, D. G., M. A. Adam, and A. D. Miller. 1990. Gene transfer by retro-virus vectors occurs only in cells that are actively replicating at the time of infection. Mol. Cell. Biol. 10:4239-4242.
15. Morgan, J. R., J. M. LeDoux, R. G. Snow, R. G. Tompkins, and M. L. Yarmush. 1995. Retrovirus infection: effect of time and target cell number. J. Virol. 69:6994-7000.
16. Naldini, L., U. Blomer, P. Gallay, D. Ory, R. Mulligan, F. H. Gage, I. M. Verma, and D. Trono. 1996. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-267.
17. Orlic, D., L. J. Girard, C. T. Jordan, S. M. Anderson, A. P. Cline, and D. M. Bodine. 1996. The level of mRNA encoding the amphotropic retrovirus receptor in mouse and human hematopoietic stem cells is low and correlates with the efficiency of retrovirus transduction. Proc. Natl. Acad. Sci. USA 93:11097-11102.
18. Paul, R. W., D. Morris, B. W. Hess, J. Dunn, and R. W. Overell. 1993. Increased viral titer through concentration of viral harvesls from retroviral packaging cell lines. Hum. Gene Ther. 4:609-615.
19. Prince, A. M. 1960. Quantitative studies on Rous sarcoma virus. V. An analysis of the mechanism of virulence of the Bryan "high liter" strain of RSV. Virology 11:371-399.
20. Rein, A. L., B. I. Gerwin, R. H. Bassin, L. Schwarm, and G. Schidlovsky. 1978. A replication-defective variant of Moloney murine leukemia virus. I. Biological characterization. J. Virol. 25:146-156.
21. Salmeen, I., L. Rimai, R. B. Luftig, L. Liebes, E. Hetzer, M. Rich, and J. J. McCormick. 1976. Hydrodynamic diameters of murine mammary, Rous sarcoma, and feline leukemia RNA tumor viruses: studies by laser beat frequency light-scattering spectroscopy and electron microscopy. J. Virol. 17:584-596.
22. Shoup, D., and A. Szabo. 1982. Chronoamperometric current at finite disk electrodes. J. Electroanal. Chem. 140:237-245.
23. Tavoloni, N. 1997. A simple procedure to determine the biological titer of recombinant retroviral vectors. Gene Ther. 4:150-155.
24. Valentine, R. C., and A. C. Allison. 1959. Virus particle adsorption. I. Theory of adsorption and experiments on the attachment of particles to non-biological surfaces. Biochim. Biophys. Acta 34:10-23.